Irinotecan & temozolomide in breast cancer patients with progressing CNS disease (Full article not available) June 6, 2019
ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician’s choice in patients with metastatic breast cancer & brain metastases May 10, 2019
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto & GeparSixto May 10, 2019
Tesetaxel brain concentrations exceeded concentrations required for tumor killing for sustained period of time in preclinical testing April 2, 2019